Merck Sharp and Dohme Corporation v. Albrecht Oral Argument

The Supreme Court heard oral argument in Merck Sharp and Dohme Corp. v. Albrecht, concerning whether drug manufacturer companies are exempt from… read more

The Supreme Court heard oral argument in Merck Sharp and Dohme Corp. v. Albrecht, concerning whether drug manufacturer companies are exempt from state-mandated warnings when the federal Food and Drug Administration rejects their proposed warning label. In this case the FDA did not approve of a warning on Merck’s osteoporosis drug, Fosamax, for increased risk of bone fractures. Patients later sued Merck under state laws, claiming the drug lacked sufficient warnings. Justice Ruth Bader Ginsburg did not participate in oral argument, as was she working from home as she recovered from cancer surgery.

On May 20, 2019, the Court ruled unanimously that the case should go back to a lower court for further proceedings. close

Report Video Issue

People in this video

More People

Hosting Organization

More information about

Merck Sharp and Dohme Corporation v. Albrecht Oral Argument

1,605 Views
Program ID:
456729-1
Category:
Public Affairs Event
Format:
Judicial Proceeding
Location:
Washington, District of Columbia, United States
First Aired:
Jan 11, 2019 | 8:00pm EST | C-SPAN 2
Last Aired:
May 21, 2019 | 6:47am EDT | C-SPAN 3

Airing Details

  • Jan 11, 2019 | 8:00pm EST | C-SPAN 2
  • Jan 12, 2019 | 1:23am EST | C-SPAN 2
  • Jan 12, 2019 | 6:56am EST | C-SPAN 2
  • Jan 14, 2019 | 1:30am EST | C-SPAN 1
  • Jan 15, 2019 | 5:10am EST | C-SPAN 2
  • Jan 25, 2019 | 1:22pm EST | C-SPAN 3
  • Feb 04, 2019 | 10:51am EST | C-SPAN 3
  • May 21, 2019 | 6:47am EDT | C-SPAN 3
Purchase a Download

Merck Sharp and Dohme Corporation v. Albrecht Oral Argument

  • MP4 video - Low
    Price:
    $3.99
  • MP4 video - Standard
    Price:
    $4.99
  • MP3 audio - Standard
    Price:
    $0.99